{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Despite the breadth of research summarized in these abstracts—which collectively illuminate key aspects of RNA processing, pre‐mRNA splicing, epigenetic regulation, and their perturbation in hematologic and other malignancies through mutations in factors such as CALR, U2AF1, SF3B1, SRSF2, and related regulators"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": ",\n none of these studies provide any experimental evidence or detailed discussion regarding the locus designated LOC102724594. In other words, while these works collectively enhance our understanding of the mechanisms underlying splicing alterations, dysregulated mRNA processing, and chromatin‐mediated transcriptional control in cancer"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "8"}]}, {"type": "t", "text": ", they do not address or characterize LOC102724594."}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n As a result, the biological function of LOC102724594 remains uncharacterized in the context of these reports. Given the important roles played by well‐established splicing factors and epigenetic regulators in maintaining normal hematopoiesis or in driving malignant transformation, it is conceivable that LOC102724594 might warrant future investigation to determine whether it participates—and if so, how it might contribute—to these critical pathways. In this light, further studies expressly focused on LOC102724594 are needed to uncover its molecular role and possible implications in disease, which could ultimately extend our understanding of RNA regulatory networks in both normal biology and cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, while the provided abstracts significantly advance the field of RNA splicing and epigenetic regulation in malignancies, they do not contain information that defines or elucidates the function of LOC102724594. Future targeted research will be necessary to determine whether LOC102724594 participates in similar regulatory mechanisms or represents a novel factor in these processes.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "J Nangalia, C E Massie, E J Baxter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa1312542"}], "href": "https://doi.org/10.1056/NEJMoa1312542"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24325359"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24325359"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "R Coleman Lindsley, Brenton G Mar, Emanuele Mazzola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Acute myeloid leukemia ontogeny is defined by distinct somatic mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2014-11-610543"}], "href": "https://doi.org/10.1182/blood-2014-11-610543"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25550361"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25550361"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "John S Welch, Allegra A Petti, Christopher A Miller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa1605949"}], "href": "https://doi.org/10.1056/NEJMoa1605949"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27959731"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27959731"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Timothy A Graubert, Dong Shen, Li Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.1031"}], "href": "https://doi.org/10.1038/ng.1031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22158538"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22158538"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kyle C Strickland, Brooke E Howitt, Sachet A Shukla, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7277"}], "href": "https://doi.org/10.18632/oncotarget.7277"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26871470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26871470"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Eunhee Kim, Janine O Ilagan, Yang Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccell.2015.04.006"}], "href": "https://doi.org/10.1016/j.ccell.2015.04.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25965569"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25965569"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Raphaël Itzykson, Olivier Kosmider, Aline Renneville, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic score including gene mutations in chronic myelomonocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2012.47.3314"}], "href": "https://doi.org/10.1200/JCO.2012.47.3314"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23690417"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23690417"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "A Tefferi, T L Lasho, C M Finke, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leukemia (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/leu.2014.3"}], "href": "https://doi.org/10.1038/leu.2014.3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24402162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24402162"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Sarah L Maguire, Andri Leonidou, Patty Wai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SF3B1 mutations constitute a novel therapeutic target in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pathol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/path.4483"}], "href": "https://doi.org/10.1002/path.4483"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25424858"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25424858"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yong Zhu, Xiuye Wang, Elmira Forouzmand, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2017.11.031"}], "href": "https://doi.org/10.1016/j.molcel.2017.11.031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29276085"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29276085"}]}]}]}